Epinephrine Injectors Recalled for Incorrect Dosage

Comments (0)

Hundreds of thousands of epinephrine injectors that are used to treat severe allergic reactions are being recalled because they may not deliver the right amount of the epinephrine. The injectors are manufactured by Sanofi.

The recall includes all Auvi-Q injectors currently on the market, which is roughly 490,000 packs of injectors. Most of the recalled packs of injectors contain two injectors. The products are used to treat allergic reactions caused by foods, insect bites, medicines or other substances. About 200,000 people in the U.S. have Sanofi's injector. 

Sanofi, a French company, has received 26 reports of malfunctions with the injectors. None of the patients who had a malfunction died. The company says that it’s critical that individuals with the injectors contact their health provider to get a prescription for an alternate device, and then to return the injector once the new one is received.

Many parents are upset about the recall. Their children may have life threatening allergies and depend on the product in a time of emergency. One parent reported that her pharmacist still had the product for sale, and said that it was not up to her to pull the products since it was a voluntary recall rather than a mandatory one.

When an individual has a life-threatening allergic reaction, they rely on their injectors. If one delivered an incorrect dosage, the results could be fatal. If you have been injured by a defective prescription drug or medical device, you have legal rights. Call the consumer attorneys at Kennedy Hodges at 855-947-0707 to learn more. You can also visit our Facebook page.


Be the first to comment!

Post a Comment

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."


Email:* (will not be published)


Notify me of follow-up comments via email.